Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Vasc Surg. 2015 Dec 15;64(2):484–493. doi: 10.1016/j.jvs.2015.01.031

Figure 5.

Figure 5

Effect of DNase-I treatment on muscle inflammation following IR. Left Images A and B, are representative micrographs of TA muscle demonstrate immunostaining for the leukocytes marker-Ly6B (brown color) in the tissue sections following IR obtained from control (A) or DNase-I treated (B) mice. Quatitative analysis of Ly6B positive cells count, KC and MPO levels are summarized in the graphs, revealed that DNase-1 treatment markedly reduced the average number of leukocytes (*P=.0054, C) but did not alter skeletal muscle KC (D) or MPO (E) levels at 24 hours following IR.